Research Development

Mundipharma’s research concentrates primarily on three therapeutic areas: pain, oncology and respiratory diseases.

  • R&D is mainly driven out of research centers in the US, UK and Germany, managed by Purdue Pharma and Mundipharma Research, which are dedicated to developing only the most effective and innovative medications
  • Through these companies, Mundipharma works on pre-clinical research, pharmaceutical development, clinical development, drug safety, regulatory affairs and scientific support of new therapeutic products

Mundipharma is constantly on the lookout for substances that offer better therapeutic options for patients, which will not only help treat their conditions but will also improve their quality of life. Mundipharma is also dedicated to developing products using only high ethical standards. Our products are the result of a dynamic relationship with our partners. As such, Mundipharma produces drugs that meet the needs of both doctors and patients.